INCE

2025.11.27

INCE Capital Portfolio Company WEFLY Signs 105 eVTOL Purchase Agreements With Three Enterprises

2025.11.25

INCE Capital’s Portfolio Company Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs

2025.10.23

INCE Capital’s Portfolio Company LiblibAI Annouces $130 Million Series B Financing

2025.09.24

INCE Capital's Portfolio Company Avenzo Therapeutics Announces $60 Million Series B Financing

2025.09.16

Dyna Robotics Raises $120 Million to Advance Robotic Foundation Models on the Path to Physical Artificial General Intelligence

2025.09.06

INCE Capital's Portfolio Company Ronovo Surgical Closes Series D Financing

2025.07.15

INCE Capital's Portfolio Company Wefly Successfully Test Flies Its New eVTOL Aircraft

2025.02.24

INCE Capital's Portfolio Company LiblibAI Closed Tens of Millions in New Financing

2025.02.17

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

2022.01.29

INCE Capital Participates in PONHU’s $45 Million Series C+ Funding